Package 68788-8445-1

{"route": ["ORAL"], "spl_id": "fb055d56-71ea-4d31-818f-9666d16605d1", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["402019"], "spl_set_id": ["761dc0f8-2f65-4615-ab49-a4bcffd40ce9"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE (68788-8445-1)", "package_ndc": "68788-8445-1", "marketing_start_date": "20240815"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8445-3)", "package_ndc": "68788-8445-3", "marketing_start_date": "20230515"}, {"sample": false, "description": "7 TABLET in 1 BOTTLE (68788-8445-7)", "package_ndc": "68788-8445-7", "marketing_start_date": "20240815"}], "brand_name": "Tadalafil", "product_id": "68788-8445_fb055d56-71ea-4d31-818f-9666d16605d1", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "68788-8445", "generic_name": "Tadalafil", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tadalafil", "active_ingredients": [{"name": "TADALAFIL", "strength": "20 mg/1"}], "application_number": "ANDA209654", "marketing_category": "ANDA", "marketing_start_date": "20230515", "listing_expiration_date": "20261231"}